ctrl K

Price Alert

Corbus Pharmaceuticals I... (CRBP)

NASDAQ: CRBP · Real-Time Price · USD

9.25

-0.38 (-3.95%)

At close: Aug 15, 2025, 3:59 PM

9.43

1.95%

After-hours: Aug 15, 2025, 04:56 PM EDT

Corbus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17.2M	13.72M	17M	25.01M
Short-Term Investments	131.86M	7.18M	42.19M	72.64M
Long-Term Investments	n/a	n/a	477.43K	477.43K
Other Long-Term Assets	385K	690.23K	155.35K	46.38K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	3.91M	192.47K	192.47K	192.47K
Total Current Assets	152.98M	23.55M	60.18M	100.2M
Property-Plant & Equipment	2.52M	4.04M	5.5M	7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.9M	4.73M	6.13M	7.53M
Total Assets	155.88M	28.27M	66.31M	107.73M
Account Payables	4.79M	3.18M	2.17M	1.78M
Deferred Revenue	n/a	6.38M	n/a	10.09M
Short-Term Debt	1.61M	16.21M	3.15M	3.86M
Other Current Liabilities	2.28M	8.74M	36.87K	7.51M
Total Current Liabilities	11.82M	31.89M	12.64M	17.01M
Long-Term Debt	n/a	n/a	15.98M	15.64M
Other Long-Term Liabilities	n/a	44.41K	22.2K	22.2K
Total Long-Term Liabilities	1.63M	3.28M	20.68M	21.61M
Total Liabilities	13.45M	35.18M	33.32M	38.62M
Total Debt	3.24M	20.88M	25.09M	26.59M
Common Stock	1K	442.00	417.00	12.52K
Retained Earnings	-476.89M	-436.68M	-392.08M	-349.73M
Comprehensive Income	35K	-1.56K	-126.09K	-62.45K
Shareholders Equity	142.43M	-6.9M	32.99M	69.11M
Total Investments	131.86M	7.18M	42.19M	72.64M